SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
FROM | TO | |
---|---|---|
AROVELLA THERAPEUTICS LIMITED | 25/10/2021 | |
SUDA PHARMACEUTICALS LTD | 05/12/2017 | 25/10/2021 |
SUDA LTD | 07/12/2012 | 05/12/2017 |
EASTLAND MEDICAL SYSTEMS LTD | 07/12/2012 |
110 Stirling Hwy, Nedlands WA 6009
Tel : +61 8 9389 8033name changed to Arovella Therapeutics Limited | 25/10/2021 |
The suspension of trading in the securities of SUDA Pharmaceuticals Ltd will be lifted immediately following the release by SUD of an announcement regarding a market update. | 25/06/2020 |
In the lead up to the company requesting a trading halt, Suda had established an independent transaction committee to assess and pursue the material licensing transaction, conducted extensive due diligence inquiries on, and an independent valuation of, the target asset, advanced negotiations of the transaction documents. ASX has now formally advised the company that there is a significant likelihood the ASX will exercise its discretion to decline Suda's application for readmission if it chooses to proceed with the proposed transaction. With ASX's current determination, it is not possible for the company to proceed with the proposed transaction. The accompanying capital raising will, accordingly, also not proceed at this time. | 25/06/2020 |
The securities of Suda Pharmaceuticals Ltd will be suspended from quotation immediately under Listing Rule 17.2, at the request of SUD, pending the release of an announcement regarding a proposed licensing transaction and a capital raising. | 05/06/2020 |
we understand that on or about this date the company consolidated its shares 1 for 25 | 22/11/2019 |
The suspension of trading in the securities of Suda Pharmaceuticals Ltd will be lifted immediately, following receipt of a response to an ASX Query. | 17/10/2018 |
The company issues a response to ASX query. | 17/10/2018 |
The securities of Suda Pharmaceuticals Ltd will be suspended from quotation immediately under Listing Rule 17.3. | 17/10/2018 |
name changed from Suda Ltd | 05/12/2017 |
Dear investogain.com.au webmaster, Good to see your posts! | 12/03/2023 21:27:42 |
DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
---|---|---|---|---|
10/11/2020 | Paul Hopper | 234,669 | $0.039 | $9,152.00 |
05/11/2020 | David Simmonds | 250,000 | $0.040 | $10,000.00 |
27/10/2020 | Michael Baker | 400,000 | $0.042 | $16,800.00 |
21/11/2019 | Paul Hopper | 200,000 | $0.062 | $12,310.00 |
10/09/2019 | Paul Hopper | 1,000,000 | $0.004 | $4,000.00 |
NAME | TITLE | DATE OF APPT |
---|---|---|
Paul Hopper | Non Exec Chairman | 15/05/2019 |
Joseph Ohayon | CFO | 01/07/2010 |
David Simmonds | Non Exec Director | 27/03/2019 |
Michael Baker | Executive Director, CEO | 02/01/2020 |
David Phillips | Executive Director | 06/04/2018 |
Phillip Hains | Company Secretary |
Date of first appointment, title may have changed.
NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
---|
Date of first appointment, title may have changed.